CAS: 82230-93-1 - 6-{[4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-[(5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy]-3-(hydroxymethyl)-5,7,9,11,13-pentamethyloxacyclotetradecane-2,10-dione (non-preferred name
Fórmula:C37H67NO14
InChI:InChI=1/C37H67NO14/c1-13-25-37(9,46)30(42)20(4)27(40)18(2)15-35(7,45)32(52-34-28(41)24(38(10)11)14-19(3)48-34)21(5)29(23(17-39)33(44)50-25)51-26-16-36(8,47-12)31(43)22(6)49-26/h18-26,28-32,34,39,41-43,45-46H,13-17H2,1-12H3
Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
---|---|---|---|---|
Erythromycin EP Impurity A REF: 4Z-E-2013CAS: 82230-93-1 | - - - | A consultar | Mar 17 Dic 24 | |
Erythromycin F REF: 3D-AE31114CAS: 82230-93-1 | Min. 95% | A consultar | Mar 21 Ene 25 |
Ref: 4Z-E-2013
10mg | A consultar | ||
25mg | A consultar | ||
50mg | A consultar | ||
100mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 17 de Diciembre de 2024
Erythromycin F
CAS:82230-93-1
Erythromycin F is a erythromycin derivative that is the most potent member of this antibiotic …
Fórmula:
C37H67NO14
Pureza:
Min. 95%
Peso molecular:
749.93 g/mol
Ref: 3D-AE31114
1mg | A consultar | ||
2mg | A consultar | ||
5mg | A consultar | ||
10mg | A consultar | ||
25mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 21 de Enero de 2025